CVS Health Corp EV/EBITDA
Data as of August 04, 2026
EV/EBITDA
28.97
Enterprise Value
$186.81B
EBITDA (TTM)
$6.45B
Sector
Health Care
How It's Calculated
28.97 = $186.81B ÷ $6.45B
What This Means
CVS Health Corp's EV/EBITDA of 29.0 is elevated, which can reflect growth expectations, scarce assets, or cyclical EBITDA.
About CVS Health Corp
CVS Health Corp (CVS) operates in the Health Care sector, specifically in Health Care. With a market capitalization of about $133.25B, it ranks as a large-cap stock — a major established company.
Shares recently traded near $105.37, within a 52-week range of $61.19 to $110.68 (-4.8% from the high, +72.2% from the low). Beta of 0.59 indicates relatively lower volatility versus the market.
Trailing profit margin is about 72.0%, signaling a strong profit margin relative to many peers.
Understanding This Metric
EV/EBITDA is widely used when comparing companies with different debt loads because enterprise value includes net debt while EBITDA approximates operating cash earnings power. For CVS Health Corp, the ratio should be read with growth, capex needs, and cycle position in Health Care. Pair EV/EBITDA with free cash flow yield and net debt metrics before drawing conclusions — especially when EBITDA is depressed or boosted by one-time items.
Using This Number in Practice
Near 28.97x EV/EBITDA, CVS Health Corp (CVS) carries an elevated EV/EBITDA multiple that may embed growth expectations or scarcity within its peer set. Enterprise value of about $186.81B and EBITDA near $6.45B form the ratio — adjust for one-time items before treating the headline multiple as comparable.
Credit and LBO workflows often sort names on EV/EBITDA before drilling into free cash flow and maintenance capex. Pair this view with the EV/EBITDA calculator and the CVS metrics hub for related valuation pages.
Sector Comparison
Among Health Care names on our S&P 100 coverage, CVS Health Corp's EV/EBITDA of 28.97 can be compared with peers such as UNH (16.32), ABT (22.61), MDT (16.53). Sector context helps interpretation, but each company's growth profile and balance sheet differ — use multiple metrics before drawing conclusions. View all Health Care stocks.
Key Takeaways
- CVS is grouped in the Health Care sector for peer comparisons.
- Recent beta of 0.59 suggests lower-than-market price sensitivity.
- Trailing profit margin of 72.0% provides context for how much earnings support the headline multiple.
Related Tools & Guides
Explore calculators and guides connected to this metric, or view all metrics for CVS.
Learn the full workflow
Compare PE with PB, PEG, EV/EBITDA, and market cap in one structured path.
Open the Stock Valuation hub →Other CVS Metrics
Frequently Asked Questions
What is CVS's EV/EBITDA?
EV/EBITDA compares enterprise value to operating earnings before interest, taxes, depreciation, and amortization. CVS Health Corp's ratio is about 28.97 — common for comparing leveraged companies in Health Care.
Is 28.97 high or low vs peers?
Among Health Care peers (e.g. ABT (22.61), MDT (16.53), UNH (16.32)), CVS's 28.97 should be read with growth, capex, and debt levels.
When is EV/EBITDA misleading?
EBITDA ignores capex, working capital, and stock-based comp; negative or tiny EBITDA makes the ratio meaningless. Cross-check with free cash flow and net debt.
Calculate the ev/ebitda for any stock with our free calculator.
Open EV/EBITDA Calculator →